These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 23401092)

  • 1. Perinatal and early infantile symptoms in congenital disorders of glycosylation.
    Funke S; Gardeitchik T; Kouwenberg D; Mohamed M; Wortmann SB; Korsch E; Adamowicz M; Al-Gazali L; Wevers RA; Horvath A; Lefeber DJ; Morava E
    Am J Med Genet A; 2013 Mar; 161A(3):578-84. PubMed ID: 23401092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital defects of glycosylation: Novel presentations with mainly neurological involvement and variable dysmorphic features.
    İnci A; Cengiz B; Biberoğlu G; Okur İ; Arhan E; Öner AY; Kasapkara ÇS; Küçükçongar A; Tümer L; Ezgu F
    Am J Med Genet A; 2021 Sep; 185(9):2739-2747. PubMed ID: 33960646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and diagnostic approach in unsolved CDG patients with a type 2 transferrin pattern.
    Mohamed M; Guillard M; Wortmann SB; Cirak S; Marklova E; Michelakakis H; Korsch E; Adamowicz M; Koletzko B; van Spronsen FJ; Niezen-Koning KE; Matthijs G; Gardeitchik T; Kouwenberg D; Lim BC; Zeevaert R; Wevers RA; Lefeber DJ; Morava E
    Biochim Biophys Acta; 2011 Jun; 1812(6):691-8. PubMed ID: 21362473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases.
    de Lonlay P; Seta N; Barrot S; Chabrol B; Drouin V; Gabriel BM; Journel H; Kretz M; Laurent J; Le Merrer M; Leroy A; Pedespan D; Sarda P; Villeneuve N; Schmitz J; van Schaftingen E; Matthijs G; Jaeken J; Korner C; Munnich A; Saudubray JM; Cormier-Daire V
    J Med Genet; 2001 Jan; 38(1):14-9. PubMed ID: 11134235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital disorders of glycosylation type IIb with MOGS mutations cause early infantile epileptic encephalopathy, dysmorphic features, and hepatic dysfunction.
    Anzai R; Tsuji M; Yamashita S; Wada Y; Okamoto N; Saitsu H; Matsumoto N; Goto T
    Brain Dev; 2021 Mar; 43(3):402-410. PubMed ID: 33261925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and genotypic spectrum of congenital disorders of glycosylation type I and type II.
    Al Teneiji A; Bruun TU; Sidky S; Cordeiro D; Cohn RD; Mendoza-Londono R; Moharir M; Raiman J; Siriwardena K; Kyriakopoulou L; Mercimek-Mahmutoglu S
    Mol Genet Metab; 2017 Mar; 120(3):235-242. PubMed ID: 28122681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital disorder of glycosylation type Ia (CDG-Ia): phenotypic spectrum of the R141H/F119L genotype.
    Kjaergaard S; Schwartz M; Skovby F
    Arch Dis Child; 2001 Sep; 85(3):236-9. PubMed ID: 11517108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALG13-CDG in a male with seizures, normal cognitive development, and normal transferrin isoelectric focusing.
    Gadomski TE; Bolton M; Alfadhel M; Dvorak C; Ogunsakin OA; Nelson SL; Morava E
    Am J Med Genet A; 2017 Oct; 173(10):2772-2775. PubMed ID: 28777499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex Phenotypes in Inborn Errors of Metabolism: Overlapping Presentations in Congenital Disorders of Glycosylation and Mitochondrial Disorders.
    Gardeitchik T; Wyckmans J; Morava E
    Pediatr Clin North Am; 2018 Apr; 65(2):375-388. PubMed ID: 29502919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, neuroradiological, and biochemical features of SLC35A2-CDG patients.
    Vals MA; Ashikov A; Ilves P; Loorits D; Zeng Q; Barone R; Huijben K; Sykut-Cegielska J; Diogo L; Elias AF; Greenwood RS; Grunewald S; van Hasselt PM; van de Kamp JM; Mancini G; Okninska A; Pajusalu S; Rudd PM; Rustad CF; Salvarinova R; de Vries BBA; Wolf NI; ; Ng BG; Freeze HH; Lefeber DJ; Õunap K
    J Inherit Metab Dis; 2019 May; 42(3):553-564. PubMed ID: 30746764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital disorder of glycosylation type Id (CDG Id): phenotypic, biochemical and molecular characterization of a new patient.
    Rimella-Le-Huu A; Henry H; Kern I; Hanquinet S; Roulet-Perez E; Newman CJ; Superti-Furga A; Bonafé L; Ballhausen D
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S381-6. PubMed ID: 18679822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALG8-CDG: novel patients and review of the literature.
    Höck M; Wegleiter K; Ralser E; Kiechl-Kohlendorfer U; Scholl-Bürgi S; Fauth C; Steichen E; Pichler K; Lefeber DJ; Matthjis G; Keldermans L; Maurer K; Zschocke J; Karall D
    Orphanet J Rare Dis; 2015 Jun; 10():73. PubMed ID: 26066342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature.
    Schiff M; Roda C; Monin ML; Arion A; Barth M; Bednarek N; Bidet M; Bloch C; Boddaert N; Borgel D; Brassier A; Brice A; Bruneel A; Buissonnière R; Chabrol B; Chevalier MC; Cormier-Daire V; De Barace C; De Maistre E; De Saint-Martin A; Dorison N; Drouin-Garraud V; Dupré T; Echenne B; Edery P; Feillet F; Fontan I; Francannet C; Labarthe F; Gitiaux C; Héron D; Hully M; Lamoureux S; Martin-Coignard D; Mignot C; Morin G; Pascreau T; Pincemaille O; Polak M; Roubertie A; Thauvin-Robinet C; Toutain A; Viot G; Vuillaumier-Barrot S; Seta N; De Lonlay P
    J Med Genet; 2017 Dec; 54(12):843-851. PubMed ID: 28954837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDG-IL: an infant with a novel mutation in the ALG9 gene and additional phenotypic features.
    Weinstein M; Schollen E; Matthijs G; Neupert C; Hennet T; Grubenmann CE; Frank CG; Aebi M; Clarke JT; Griffiths A; Seargeant L; Poplawski N
    Am J Med Genet A; 2005 Jul; 136(2):194-7. PubMed ID: 15945070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of ALG11-congenital disorders of glycosylation diagnosed by post-mortem whole exome sequencing.
    Arai Y; Okanishi T; Kanai S; Okazaki T; Koshimizu E; Miyatake S; Maeoka Y; Fujimoto A; Matsumoto N; Maegaki Y
    Brain Dev; 2022 Nov; 44(10):732-736. PubMed ID: 35907674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Congenital Disorders of Glycosylation in Childhood Epilepsy and Effects of Anti-Epileptic Drugs on the Transferrin Isoelectric Focusing Test.
    Silver G; Bahl S; Cordeiro D; Thakral A; Athey T; Mercimek-Andrews S
    Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten years of screening for congenital disorders of glycosylation in Argentina: case studies and pitfalls.
    Asteggiano CG; Papazoglu M; Bistué Millón MB; Peralta MF; Azar NB; Spécola NS; Guelbert N; Suldrup NS; Pereyra M; Dodelson de Kremer R
    Pediatr Res; 2018 Dec; 84(6):837-841. PubMed ID: 30397276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the phenotype in congenital disorder of glycosylation due to ALG1 mutations.
    Morava E; Vodopiutz J; Lefeber DJ; Janecke AR; Schmidt WM; Lechner S; Item CB; Sykut-Cegielska J; Adamowicz M; Wierzba J; Zhang ZH; Mihalek I; Stockler S; Bodamer OA; Lehle L; Wevers RA
    Pediatrics; 2012 Oct; 130(4):e1034-9. PubMed ID: 22966035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal transferrin patterns in congenital disorders of glycosylation with Golgi homeostasis disruption: apolipoprotein C-III at the rescue!
    Raynor A; Vincent-Delorme C; Alaix AS; Cholet S; Dupré T; Vuillaumier-Barrot S; Fenaille F; Besmond C; Bruneel A
    Clin Chim Acta; 2021 Aug; 519():285-290. PubMed ID: 34022244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital disorders of glycosylation.
    Jaeken J
    Ann N Y Acad Sci; 2010 Dec; 1214():190-8. PubMed ID: 21175687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.